Optimization of indications for parasternal radiotherapy in patients with breast cancer
https://doi.org/10.17650/1994-4098-2014-0-1-49-57
Abstract
Detection of regional lymph nodes involvement is an extremely important step in the diagnosis and treatment of breast cancer. As with axillary lymph node metastases, parasternal lymph nodes metastases are an important prognostic factor. 1125 patients with breast cancer were under- went to thoracoscopicinternal mammary lymphadenectomy. Metastases were found in 204 of 1125 cases (18,3 %), representing 33,9 % of all cases of regional metastases (n = 601). Median overall survival in patients with internal mammary lymph nodes metastases who received radiation therapy and appropriate systemic treatment was 7,8 years, which is contrary to the earlier experience and is consistent with the results of the last years publications. We believe this excellent result is due to irradiation of the internal mammary nodes, and we believe that the thoracoscopic internal mammary lymphadenectomy should be a part of the diagnostic process in patients with breast cancer.
About the Authors
A. A. Zaytceva
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
A. V. Petrovsky
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
V. A. Uymanov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. V. Trigolosov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Ya. V. Vishnevskaya
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I. A. Gladilina
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
K. V. Afanasyeva
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
D. B. Maslyankin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
S. B. Polikarpova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
M. I. Nechushkin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Veronesi U., Arnone P., Veronesi P. et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 2008;19(9):1553–60.
2. Триголосов А.В. Видеоторакоскопическая парастернальная лимфодиссекция в диагностике распространенности и лечении рака молочной железы. Дис. ... канд. мед. наук. М., 2002.
3. Veronesi U. Removal of internal mammary nodes in cancer of the breast: report of 350 cases. Acta Unio Int Contra Cancrum 1963;19:1560–5.
4. Cody H.S.3rd, Urban J.A. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995;2(1):32–7.
5. Dupont E.L., Salud C.J., Peltz E.S. et al. Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 2001;182(4):321–4.
6. Goyal A., Newcombe R.G., Mansel R.E. et al. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 2005;41(2): 238–43.
7. Островцев Л.Д. Клинические аспекты регионарного лимфатического метастазирования рака молочной железы. Дис. ... д-ра мед. наук. М., 1982.
8. Sarp S., Fioretta G., Verkooijen H.M. et al. Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Ann Surg Oncol 2007;14(3):1031–9.
9. Musat E., Poortmans P., Van den Bogaert W. et al. Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. Eur J Cancer 2007;43(4):718–24.
10. Stemmer S.M., Rizel S., Hardan I. et al. The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: a prospective sequential nonrandomized study. J Clin Oncol 2003;21(14):2713–8.
11. Auberdiac P., Cartier L., Chargari C. et al. Internal mammary chain irradiation in breast cancer: state of the art. Cancer Radiother 2011;15(2):148–53.
12. Matzinger O., Heimsoth I., Poortmans P. et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010;49(1):24–4.
13. Chargari C., Castadot P., Macdermed D. et al. Internal mammary lymph node irradiation contributes to heart dose in breast cancer. Med Dosim 2010;35(3):163–8.
14. Edge S., Byrd D., Compton C. et al. (eds.) AJCC Cancer Staging Manual, 7th edn. New York, NY: Springer,
15.
16. Lacour J., Bucalossi P., Cacers E. et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer 1976;37(1):206–4.
17. Veronesi U., Cascinelli N., Greco M. et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985;202(6):702–7.
Review
For citations:
Zaytceva A.A., Petrovsky A.V., Uymanov V.A., Trigolosov A.V., Vishnevskaya Ya.V., Gladilina I.A., Afanasyeva K.V., Maslyankin D.B., Polikarpova S.B., Nechushkin M.I. Optimization of indications for parasternal radiotherapy in patients with breast cancer. Tumors of female reproductive system. 2014;(1):49-57. (In Russ.) https://doi.org/10.17650/1994-4098-2014-0-1-49-57
Views:
589
Email this article 